ABSTRACT
Children born to obese mothers are prone to develop asthma and airway hyperresponsiveness, but the mechanisms behind this are unclear. Here we developed a mouse model of maternal diet-induced obesity that recapitulates metabolic abnormalities seen in humans born to obese mothers. Offspring of dams fed a high-fat diet (HFD) showed increased adiposity, hyperinsulinemia, and insulin resistance at 16 wk of age despite being fed only a regular diet (RD). Bronchoconstriction induced by inhaled 5-hydroxytriptamine was also significantly increased in offspring of HFD-fed versus RD-fed dams. Increased bronchoconstriction was blocked by vagotomy, indicating this reflex was mediated by airway nerves. Three-dimensional (3-D) confocal imaging of tracheas collected from 16-wk-old offspring showed that both epithelial sensory innervation and substance P expression were increased in the offspring of HFD-fed dams compared with offspring of RD-fed dams. For the first time, we show that maternal high-fat diet increases airway sensory innervation in offspring, leading to reflex airway hyperresponsiveness.NEW & NOTEWORTHY Our study reveals a novel potential mechanism, by which maternal high-fat diet increases the risk and severity of asthma in offspring. We found that exposure to maternal high-fat diet in mice leads to hyperinnervation of airway sensory nerves and increased reflex bronchoconstriction in offspring fed a regular diet only. These findings have important clinical implications and provide new insights into the pathophysiology of asthma, highlighting the need for preventive strategies in this patient population.
Subject(s)
Asthma , Prenatal Exposure Delayed Effects , Respiratory Hypersensitivity , Humans , Female , Child , Animals , Mice , Diet, High-Fat/adverse effects , Adult Children , Bronchoconstriction , Obesity , Reflex , Asthma/etiologyABSTRACT
Obesity increases incidence and severity of asthma but the molecular mechanisms are not completely understood. Hyperinsulinemia potentiates vagally induced bronchoconstriction in obese rats. Since bronchoconstriction results from airway smooth muscle contraction, we tested whether insulin changed agonist-induced airway smooth muscle contraction. Obesity-prone and resistant rats were fed a low-fat diet for 5 wk and treated with insulin (Lantus, 3 units/rat sc) 16 h before vagally induced bronchoconstriction was measured. Ex vivo, contractile responses to methacholine were measured in isolated rat tracheal rings and human airway smooth muscle strips before and after incubation (0.5-2 h) with 100 nM insulin or 13.1 nM insulin like growth factor-1 (IGF-1). M2 and M3 muscarinic receptor mRNA expression was quantified by qRT-PCR and changes in intracellular calcium were measured in response to methacholine or serotonin in isolated rat tracheal smooth muscle cells treated with 1 µM insulin. Insulin, administered to animals 16 h prior, potentiated vagally induced bronchoconstriction in both obese-prone and resistant rats. Insulin, not IGF-1, significantly increased methacholine-induced contraction of rat and human isolated airway smooth muscle. In cultured rat tracheal smooth muscle cells, insulin significantly increased M2, not M3, mRNA expression and enhanced methacholine- and serotonin-induced increase in intracellular calcium. Insulin alone did not cause an immediate increase in intracellular calcium. Thus, insulin acutely potentiated agonist-induced increase in intracellular calcium and airway smooth muscle contraction. These findings may explain why obese individuals with hyperinsulinemia are prone to airway hyperreactivity and give insights into future targets for asthma treatment.
Subject(s)
Bronchial Hyperreactivity/pathology , Bronchoconstriction , Hyperinsulinism/complications , Insulin/adverse effects , Methacholine Chloride/pharmacology , Muscle Contraction , Muscle, Smooth/pathology , Animals , Bronchial Hyperreactivity/etiology , Bronchial Hyperreactivity/metabolism , Calcium/metabolism , Humans , Hypoglycemic Agents/adverse effects , Male , Muscarinic Agonists/pharmacology , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Obesity/complications , Rats , Rats, Sprague-Dawley , Receptors, Muscarinic/metabolism , Trachea/drug effects , Trachea/pathology , Vagus Nerve/physiopathologyABSTRACT
Obesity-related asthma often presents with more severe symptoms than non-obesity-related asthma and responds poorly to current treatments. Both insulin resistance and hyperinsulinemia are common in obesity. We have shown that increased insulin mediates airway hyperreactivity in diet-induced obese rats by causing neuronal M2 muscarinic receptor dysfunction, which normally inhibits acetylcholine release from parasympathetic nerves. Decreasing insulin with streptozotocin prevented airway hyperreactivity and M2 receptor dysfunction. The objective of the present study was to investigate whether pioglitazone, a hypoglycemic drug, prevents airway hyperreactivity and M2 receptor dysfunction in obese rats. Male rats fed a low- or high-fat diet were treated with pioglitazone or PBS by daily gavage. Body weight, body fat, fasting insulin, and bronchoconstriction and bradycardia in response to electrical stimulation of vagus nerves and to aerosolized methacholine were recorded. Pilocarpine, a muscarinic receptor agonist, was used to measure M2 receptor function. Rats on a high-fat diet had potentiated airway responsiveness to vagal stimulation and dysfunctional neuronal M2 receptors, whereas airway responsiveness to methacholine was unaffected. Pioglitazone reduced fasting insulin and prevented airway hyperresponsiveness and M2 receptor dysfunction but did not change inflammatory cytokine mRNA expression in alveolar macrophages. High-fat diet, with and without pioglitazone, had tissue-specific effects on insulin receptor mRNA expression. In conclusion, pioglitazone prevents vagally mediated airway hyperreactivity and protects neuronal M2 muscarinic receptor function in obese rats.
Subject(s)
Bronchial Hyperreactivity/drug therapy , Hyperinsulinism/drug therapy , Insulin/metabolism , Neurons/drug effects , Obesity/complications , Pioglitazone/pharmacology , Receptor, Muscarinic M2/metabolism , Animals , Bronchial Hyperreactivity/etiology , Bronchial Hyperreactivity/metabolism , Bronchial Hyperreactivity/pathology , Diet, High-Fat/adverse effects , Hyperinsulinism/etiology , Hyperinsulinism/metabolism , Hyperinsulinism/pathology , Hypoglycemic Agents/pharmacology , Male , Neurons/metabolism , Neurons/pathology , Rats , Rats, Sprague-Dawley , Receptor, Muscarinic M2/geneticsABSTRACT
Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.
Subject(s)
Asthma/drug therapy , Bronchial Hyperreactivity/drug therapy , Bronchoconstriction , Diet, High-Fat/adverse effects , Hyperinsulinism/prevention & control , Metformin/pharmacology , Obesity/complications , Animals , Asthma/chemically induced , Asthma/metabolism , Asthma/pathology , Bronchial Hyperreactivity/chemically induced , Bronchial Hyperreactivity/metabolism , Bronchial Hyperreactivity/pathology , Bronchoconstrictor Agents/toxicity , Female , Glucose/metabolism , Hyperinsulinism/etiology , Hyperinsulinism/metabolism , Hyperinsulinism/pathology , Hypoglycemic Agents/pharmacology , Male , Methacholine Chloride/toxicity , Rats , Rats, Sprague-Dawley , Vagus Nerve/drug effects , Weight GainABSTRACT
Eosinophils mediate airway hyperresponsiveness by increasing vagally mediated reflex bronchoconstriction. Here, we tested whether circulating or airway eosinophils change nerve function. Airway resistance in response to aerosolized 5-hydroxytryptamine (5-HT, 10-300 mM) was measured in wild-type mice or transgenic mice that overexpress IL5 in T cells (+IL5T), overexpress IL5 in airway epithelium (+IL5AE), or overexpress IL5 but are devoid of eosinophils (+IL5AE/-Eos). Inflammatory cells in bronchoalveolar lavage (BAL), blood, and bone marrow were quantified. Blood eosinophils were increased in +IL5T and +IL5AE mice compared with wild-type mice. +IL5T mice had increased eosinophils in bone marrow while +IL5AE mice had increased eosinophils in BAL. Eosinophils surrounding large airways were significantly increased only in +IL5AE mice. With intact vagal innervation, aerosolized 5-HT significantly increased airway resistance in +IL5AE mice. 5-HT-induced bronchoconstriction was blocked by vagotomy or atropine, demonstrating that it was mediated via a vagal reflex. Airway resistance was not increased in +IL5AE/-Eos mice, demonstrating that it required lung eosinophils, but was not affected by increased bone marrow or blood eosinophils or by increased IL5 in the absence of eosinophils. Eosinophils did not change M3 function on airway smooth muscle, since airway responses to methacholine in vagotomized mice were not different among strains. Eosinophils surrounding large airways were sufficient, even in the absence of increased IL5 or external insult, to increase vagally mediated reflex bronchoconstriction. Specifically blocking or reducing eosinophils surrounding large airways may effectively inhibit reflex hyperresponsiveness mediated by vagus nerves in eosinophilic asthma.
Subject(s)
Bronchoconstriction , Eosinophils/pathology , Lung/pathology , Lung/physiopathology , Reflex , Vagus Nerve/pathology , Airway Resistance , Animals , Bone Marrow/pathology , Bronchoalveolar Lavage , Cell Count , Disease Models, Animal , Female , Male , Mice, Inbred C57BL , Pulmonary Eosinophilia/metabolism , Pulmonary Eosinophilia/pathology , Pulmonary Eosinophilia/physiopathology , Receptor, Muscarinic M3/metabolism , Respiratory Hypersensitivity/physiopathology , Serotonin , VagotomySubject(s)
Asthma , Insulin Resistance , Humans , Insulin/therapeutic use , Asthma/etiology , Obesity/complicationsABSTRACT
Respiratory viruses cause asthma exacerbations. Because eosinophils are the prominent leukocytes in the airways of 60-70% of patients with asthma, we evaluated the effects of eosinophils on a common respiratory virus, parainfluenza 1, in the lung. Eosinophils recruited to the airways of wild-type mice after ovalbumin sensitization and challenge significantly decreased parainfluenza virus RNA in the lungs 4 days after infection compared with nonsensitized animals. This antiviral effect was also seen in IL-5 transgenic mice with an abundance of airway eosinophils (NJ.1726) but was lost in transgenic eosinophil-deficient mice (PHIL) and in IL-5 transgenic mice crossed with eosinophil-deficient mice (NJ.1726-PHIL). Loss of the eosinophil granule protein eosinophil peroxidase, using eosinophil peroxidase-deficient transgenic mice, did not reduce eosinophils' antiviral effect. Eosinophil antiviral mechanisms were also explored in vitro. Isolated human eosinophils significantly reduced parainfluenza virus titers. This effect did not involve degradation of viral RNA by eosinophil granule RNases. However, eosinophils treated with a nitric oxide synthase inhibitor lost their antiviral activity, suggesting eosinophils attenuate viral infectivity through production of nitric oxide. Consequently, eosinophil nitric oxide production was measured with an intracellular fluorescent probe. Eosinophils produced nitric oxide in response to virus and to a synthetic agonist of the virus-sensing innate immune receptor, Toll-like receptor (TLR) 7. IFNγ increased expression of eosinophil TLR7 and potentiated TLR7-induced nitric oxide production. These results suggest that eosinophils promote viral clearance in the lung and contribute to innate immune responses against respiratory virus infections in humans.
Subject(s)
Antiviral Agents/immunology , Eosinophils/immunology , Paramyxovirinae/immunology , Animals , Eosinophils/enzymology , Female , Humans , Interferon-gamma/metabolism , Lung/immunology , Lung/pathology , Lung/virology , Macaca mulatta , Mice, Inbred C57BL , Nitric Oxide/metabolism , Ovalbumin/immunology , Paramyxoviridae Infections/immunology , Paramyxoviridae Infections/virology , Paramyxovirinae/pathogenicity , Peroxidase/metabolism , Ribonucleases/metabolism , Toll-Like Receptor 7/metabolismABSTRACT
Obesity is a substantial risk factor for developing asthma, but the molecular mechanisms underlying this relationship are unclear. We tested the role of insulin in airway responsiveness to nerve stimulation using rats genetically prone or resistant to diet-induced obesity. Airway response to vagus nerve stimulation and airway M2 and M3 muscarinic receptor function were measured in obese-prone and -resistant rats with high or low circulating insulin. The effects of insulin on nerve-mediated human airway smooth muscle contraction and human M2 muscarinic receptor function were tested in vitro. Our data show that increased vagally mediated bronchoconstriction in obesity is associated with hyperinsulinemia and loss of inhibitory M2 muscarinic receptor function on parasympathetic nerves. Obesity did not induce airway inflammation or increase airway wall thickness. Smooth muscle contraction to acetylcholine was not increased, indicating that hyperresponsiveness is mediated at the level of airway nerves. Reducing serum insulin with streptozotocin protected neuronal M2 receptor function and prevented airway hyperresponsiveness to vagus nerve stimulation in obese rats. Replacing insulin restored dysfunction of neuronal M2 receptors and airway hyperresponsiveness to vagus nerve stimulation in streptozotocin-treated obese rats. Treatment with insulin caused loss of M2 receptor function, resulting in airway hyperresponsiveness to vagus nerve stimulation in obese-resistant rats, and inhibited human neuronal M2 receptor function in vitro. This study shows that it is not obesity per se but hyperinsulinemia accompanying obesity that potentiates vagally induced bronchoconstriction by inhibiting neuronal M2 muscarinic receptors and increasing acetylcholine release from airway parasympathetic nerves.
Subject(s)
Asthma/etiology , Bronchial Hyperreactivity/etiology , Bronchoconstriction , Hyperinsulinism/complications , Lung/innervation , Obesity/complications , Vagus Nerve/physiopathology , Acetylcholine/metabolism , Acetylcholine/pharmacology , Animals , Asthma/metabolism , Asthma/physiopathology , Bronchial Hyperreactivity/metabolism , Bronchial Hyperreactivity/physiopathology , Bronchial Hyperreactivity/prevention & control , Bronchoconstriction/drug effects , Bronchoconstrictor Agents/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Electric Stimulation , Humans , Hyperinsulinism/metabolism , Hyperinsulinism/physiopathology , Hypoglycemic Agents/pharmacology , Insulin/metabolism , Insulin/pharmacology , Muscarinic Agonists/pharmacology , Neural Inhibition , Obesity/metabolism , Obesity/physiopathology , Rats , Receptor, Muscarinic M2/metabolism , Receptor, Muscarinic M3/metabolism , Streptozocin/pharmacology , Time Factors , Vagus Nerve/drug effects , Vagus Nerve/metabolismABSTRACT
Eosinophils, recognized for their immune and remodeling functions and participation in allergic inflammation, have recently garnered attention due to their impact on host metabolism, especially in the regulation of adipose tissue. Eosinophils are now known for their role in adipocyte beiging, adipokine secretion, and adipose tissue inflammation. This intricate interaction involves complex immune and metabolic processes, carrying significant implications for systemic metabolic health. Importantly, the interplay between eosinophils and adipocytes is bidirectional, revealing the dynamic nature of the immune-metabolic axis in adipose tissue. While the homeostatic regulatory role of eosinophils in adipose tissue is appreciated, this relationship in the context of obesity or allergic inflammation is much less understood. Mechanistic details of eosinophil-adipose interactions, especially the direct regulation of adipocytes by eosinophils, are also lacking. Another poorly understood aspect is the metabolism of the eosinophils themselves, encompassing metabolic shifts during eosinophil subset transitions in different tissue microenvironments, along with potential effects of host metabolism on the programming of eosinophil hematopoiesis and the resulting plasticity. This review consolidates recent research in this emerging and fascinating frontier of eosinophil investigation, identifying unexplored areas and presenting innovative perspectives on eosinophil biology in the context of metabolic disorders and associated health conditions, including asthma.
Subject(s)
Asthma , Eosinophils , Metabolic Diseases , Humans , Eosinophils/metabolism , Eosinophils/immunology , Asthma/metabolism , Asthma/immunology , Asthma/pathology , Animals , Metabolic Diseases/metabolism , Metabolic Diseases/immunology , Metabolic Diseases/pathology , Adipose Tissue/metabolism , Adipose Tissue/immunology , Adipocytes/metabolismABSTRACT
Obesity-induced asthma responds poorly to all current pharmacological interventions, including steroids, suggesting that classic, eosinophilic inflammation is not a mechanism. Since insulin resistance and hyperinsulinemia are common in obese individuals and associated with increased risk of asthma, we used diet-induced obese mice to study how insulin induces airway hyperreactivity. Inhaled 5-HT or methacholine induced dose-dependent bronchoconstriction that was significantly potentiated in obese mice. Cutting the vagus nerves eliminated bronchoconstriction in both obese and nonobese animals, indicating that it was mediated by a neural reflex. There was significantly greater density of airway sensory nerves in obese compared with nonobese mice. Deleting insulin receptors on sensory nerves prevented the increase in sensory nerve density and prevented airway hyperreactivity in obese mice with hyperinsulinemia. Our data demonstrate that high levels of insulin drives obesity-induced airway hyperreactivity by increasing sensory innervation of the airways. Therefore, pharmacological interventions to control metabolic syndrome and limit reflex-mediated bronchoconstriction may be a more effective approach to reduce asthma exacerbations in obese and patients with asthma.
Subject(s)
Asthma , Hyperinsulinism , Mice , Animals , Bronchoconstriction/physiology , Mice, Obese , Methacholine Chloride/pharmacology , Insulin/metabolism , Receptor, Insulin , Serotonin , Asthma/metabolism , Reflex , Hyperinsulinism/complications , Obesity/complicationsABSTRACT
Eosinophils affect nerve structure and function in organs such as lungs and skin, which contributes to disease pathogenesis. We have developed methods for culturing primary sensory and parasympathetic neurons in multiple species and have refined these techniques for coculture with eosinophils. Eosinophil-nerve coculture has been an essential tool for testing interactions between these cell types. Here we describe methods for coculturing primary parasympathetic ganglia, vagal sensory nerves, and dorsal root sensory nerves with eosinophils.
Subject(s)
Coculture Techniques/methods , Eosinophils/metabolism , Neurons/metabolism , Animals , Cell Culture Techniques/methods , Eosinophils/physiology , Ganglia, Parasympathetic/metabolism , Ganglia, Spinal/metabolism , Guinea Pigs , Humans , Nerve Tissue/metabolism , Neurons/physiology , Parasympathetic Nervous System/metabolism , Sensory Receptor Cells/metabolism , Trachea/cytology , Vagus Nerve/metabolismABSTRACT
Obesity affects more than 650 million adults worldwide and is a major risk factor for a variety of serious comorbidities. The prevalence of obesity has tripled in the past forty years and continues to rise. Eosinophils have recently been implicated in providing a protective role against obesity. Decreasing eosinophils exacerbates weight gain and contributes to glucose intolerance in high fat diet-induced obese animals, while increasing eosinophils prevents high-fat diet-induced adipose tissue and body weight gain. Human studies, however, do not support a protective role for eosinophils in obesity. More recent animal studies have also reported conflicting results. Considering these contradictory findings, the relationship between eosinophils and obesity may not be unidirectional. In this mini-review, we summarize a recent debate regarding the role of adipose tissue eosinophils in metabolic disorders, and discuss local and systemic effects of eosinophils in obesity. Given that adipose eosinophils play a role in tissue homeostasis, more research is needed to understand the primary function of adipose tissue eosinophils in their microenvironment. Therapeutic interventions that target eosinophils in adipose tissue may have the potential to reduce inflammation and body fat, while improving metabolic dysfunction in obese patients.
Subject(s)
Eosinophils/pathology , Obesity/pathology , Adipose Tissue/pathology , Animals , Asthma/complications , Asthma/pathology , Cell Communication , Humans , Obesity/complicationsABSTRACT
Eosinophils cluster around airway nerves in patients with fatal asthma and in antigen-challenged animals. Activated eosinophils release major basic protein, which blocks inhibitory M2 muscarinic receptors (M2Rs) on nerves, increasing acetylcholine release and potentiating vagally mediated bronchoconstriction. We tested whether GW701897B, an antagonist of CCR3 (the receptor for eotaxin as well as a group of eosinophil active chemokines), affected vagal reactivity and M2R function in ovalbumin-challenged guinea pigs. Sensitized animals were treated with the CCR3 antagonist before inhaling ovalbumin. Antigen-challenged animals were hyperresponsive to vagal stimulation, but those that received the CCR3 antagonist were not. M2R function was lost in antigen-challenged animals, but not in those that received the CCR3 antagonist. Although the CCR3 antagonist did not decrease the number of eosinophils in lung tissues as assessed histologically, CCR3 antagonist prevented antigen-induced clustering of eosinophils along the nerves. Immunostaining revealed eotaxin in airway nerves and in cultured airway parasympathetic neurons from both guinea pigs and humans. Both IL-4 and IL-13 increased expression of eotaxin in cultured airway parasympathetic neurons as well as in human neuroblastoma cells. Thus, signaling via CCR3 mediates eosinophil recruitment to airway nerves and may be a prerequisite to blockade of inhibitory M2Rs by eosinophil major basic protein.
Subject(s)
Bronchial Hyperreactivity/immunology , Chemokines, CC/physiology , Neurons/physiology , Receptor, Muscarinic M2/physiology , Receptors, Chemokine/antagonists & inhibitors , Animals , Bronchial Hyperreactivity/physiopathology , Bronchoalveolar Lavage Fluid , Chemokine CCL11 , Chemokines, CC/analysis , Disease Models, Animal , Female , Guinea Pigs , Ovalbumin/immunology , Parasympathetic Nervous System/immunology , Receptors, CCR3 , Receptors, Chemokine/physiology , Receptors, Interleukin-4/analysisABSTRACT
In asthma, airway nerve dysfunction leads to excessive bronchoconstriction and cough. It is well established that eosinophils alter nerve function and that airway eosinophilia is present in 50 to 60% of asthmatics. However, the effects of eosinophils on airway nerve structure have not been established. We tested whether eosinophils alter airway nerve structure and measured the physiological consequences of those changes. Our results in humans with and without eosinophilic asthma showed that airway innervation and substance P expression were increased in moderate persistent asthmatics compared to mild intermittent asthmatics and healthy subjects. Increased innervation was associated with a lack of bronchodilator responsiveness and increased irritant sensitivity. In a mouse model of eosinophilic airway inflammation, the increase in nerve density and airway hyperresponsiveness were mediated by eosinophils. Our results implicate airway nerve remodeling as a key mechanism for increased irritant sensitivity and exaggerated airway responsiveness in eosinophilic asthma.
Subject(s)
Asthma/pathology , Eosinophils/pathology , Lung/innervation , Adult , Aged , Animals , Asthma/blood , Asthma/complications , Asthma/physiopathology , Bronchoconstriction/drug effects , Bronchodilator Agents/pharmacology , Eosinophils/drug effects , Female , Humans , Lung/drug effects , Lung/physiopathology , Male , Mice, Inbred C57BL , Middle Aged , Neurons/drug effects , Quality of Life , Reflex/drug effects , Respiratory Hypersensitivity/complications , Respiratory Hypersensitivity/pathology , Respiratory Hypersensitivity/physiopathology , Substance P/metabolism , Young AdultABSTRACT
Airway eosinophils are increased in asthma and are especially abundant around airway nerves. Nerves control bronchoconstiction and in asthma, airway hyperreactivity (where airways contract excessively to inhaled stimuli) develops when eosinophils alter both parasympathetic and sensory nerve function. Eosinophils release major basic protein, which is an antagonist of inhibitory M2 muscarinic receptors on parasympathetic nerves. Loss of M2 receptor inhibition potentiates parasympathetic nerve-mediated bronchoconstriction. Eosinophils also increase sensory nerve responsiveness by lowering neurons' activation threshold, stimulating nerve growth, and altering neuropeptide expression. Since sensory nerves activate parasympathetic nerves via a central neuronal reflex, eosinophils' effects on both sensory and parasympathetic nerves potentiate bronchoconstriction. This review explores recent insights into mechanisms and effects of eosinophil and airway nerve interactions in asthma.
Subject(s)
Asthma/physiopathology , Bronchoconstriction/immunology , Eosinophils/metabolism , Lung/innervation , Animals , Asthma/immunology , Humans , Lung/immunology , Parasympathetic Nervous System/immunology , Parasympathetic Nervous System/physiopathology , Sensory Receptor Cells/immunology , Sensory Receptor Cells/physiologyABSTRACT
Resistin levels are increased in obesity, and hyperresistinemia impairs glucose homeostasis in rodents. Here, we have determined the role of resistin in ob/ob mice that are obese and insulin resistant because of genetic deficiency of leptin. Loss of resistin increased obesity in ob/ob mice by further lowering the metabolic rate without affecting food intake. Nevertheless, resistin deficiency improved glucose tolerance and insulin sensitivity in these severely obese mice, largely by enhancing insulin-mediated glucose disposal in muscle and adipose tissue. In contrast, in C57BL/6J mice with diet-induced obesity but wild-type leptin alleles, resistin deficiency reduced hepatic glucose production and increased peripheral glucose uptake. Resistin deficiency enhanced Akt phosphorylation in muscle and liver and decreased suppressor of cytokine signaling-3 level in muscle, and these changes were reversed by resistin replacement. Together, these results provide strong support for an important role of resistin in insulin resistance and diabetes associated with genetic or diet-induced obesity.
Subject(s)
Glucose/metabolism , Insulin Resistance/physiology , Leptin/deficiency , Leptin/genetics , Resistin/deficiency , Aging , Animals , Eating , Energy Metabolism , Homeostasis , Kinetics , Liver/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Oxygen Consumption , Resistin/geneticsABSTRACT
Studies of experimental motor neuron degeneration attributable to expression of neurofilament light chain (NF-L) transgenes have raised the possibility that the neuropathic effects result from overexpression of NF-L mRNA, independent of NF-L protein effects (Cañete-Soler et al., 1999). The present study was undertaken to test for an RNA-mediated pathogenesis. Transgenic mice were derived using either an enhanced green fluorescent protein reporter construct or modified chimeric constructs that differ only in their 3' untranslated regions (UTRs). Motor function and spinal cord histology were normal in mice expressing the unmodified reporter transgene. In mice expressing a chimeric transgene in which sequence of NF-L 3' UTR was inserted into the 3' UTR of the reporter transgene, we observed growth retardation and reduced kinetic activity during postnatal development. Older mice developed impairment of motor function and atrophy of nerve fibers in the ventral roots. A similar but more severe phenotype was observed when the chimeric transgene contained a 36 bp c-myc insert in an mRNA destabilizing element of the NF-L sequence. Our results suggest that neuropathic effects of overexpressing NF-L can occur at the level of transgene RNA and are mediated by sequences in the NF-L 3' UTR.
Subject(s)
3' Untranslated Regions/genetics , Growth Disorders/genetics , Motor Neuron Disease/physiopathology , Motor Neurons/metabolism , Neurofilament Proteins/genetics , Animals , Behavior, Animal , Body Weight/genetics , COS Cells , Genes, Reporter , Genes, myc/genetics , Growth Disorders/pathology , Luminescent Proteins/genetics , Mice , Mice, Transgenic , Motor Activity/genetics , Motor Neuron Disease/genetics , Motor Neuron Disease/pathology , Motor Neurons/drug effects , Motor Neurons/pathology , Mutation , Neurofilament Proteins/biosynthesis , Neurofilament Proteins/pharmacology , Phenotype , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transgenes/physiology , Vacuoles/pathologyABSTRACT
The mechanisms whereby mutant gene expression triggers neurodegeneration are poorly understood but have generally been attributed to translated gene products. We now demonstrate direct neuropathic effects of untranslated RNA on cultured motor neurons. We show that expression of untranslated light neurofilament (NF-L) RNA sequence in the 3'UTR of an EGFP transgene (pEGFP/NF-L RNA) or in a separate expression vector (pRc/NF-L RNA) causes dose-dependent, neuron-specific motor neuron degeneration. Neither unfused EGFP protein (pEGFP/wt) nor EGFP-tagged NF-L protein (pEGFP/NF-L protein) has similar neuropathic effects. The findings are the first demonstration of a direct RNA-mediated neurotoxic effect. Moreover, the resulting neuropathological changes show that untranslated RNA can lead to early degeneration of neuritic processes and accumulations of ubiquitinated aggregates in the perikarya and nuclei of degenerating motor neurons. The latter findings are hallmark neuropathological features of neurodegenerative diseases and their occurrence as a result of altered RNA expression raises the prospects of an RNA-mediated component in the pathogenesis of neurodegenerative states.
Subject(s)
Motor Neurons/metabolism , Nerve Degeneration/metabolism , Neurofilament Proteins/biosynthesis , RNA/biosynthesis , Ubiquitins/biosynthesis , Animals , Cell Aggregation/physiology , Cell Survival/physiology , Cells, Cultured , Gene Expression Regulation/physiology , Mice , Motor Neurons/pathology , Nerve Degeneration/pathology , Neurofilament Proteins/genetics , RNA/metabolism , Spinal Cord/metabolism , Spinal Cord/pathology , Ubiquitins/geneticsABSTRACT
p190RhoGEF is a large multi-functional protein with guanine nucleotide exchange (GEF) activity. The C-terminal region of p190RhoGEF is a highly interactive domain that binds multiple factors, including proteins with anti-apoptotic activities. We now report that transfection of EGFP-tagged p190RhoGEF protects Neuro 2a cells from stress-induced apoptosis and that anti-apoptotic activity is localized to cytoplasmic retention sequences (CRS-1 and CRS-2) in the C-terminal region of p190RhoGEF. Cytoplasmic retention is conferred to an EGFP fluorescent marker when fused to either CRS-1 or CRS-2. Both cytoplasmic retention and anti-apoptotic activity are lost by deleting CRS-1 and CRS-2 in the p190RhoGEF sequence and can be recovered by restoring either CRS-1 or CRS-2 to the EGFP-tagged sequence. Since the CRS-1 and CRS-2 contain the JIP-1 and 14-3-3 binding sites, we propose that anti-apoptotic activity may be conferred by the binding of p190RhoGEF to JIP-1 or 14-3-3, possibly by altering their interactive properties or nucleocytoplasmic movements. Taken together, our findings support a model whereby multiple interactions of p190RhoGEF confer homeostatic properties to differentiated neurons and may link neuronal homeostasis to the regulation of NF-L expression.
Subject(s)
Apoptosis/physiology , Cytoplasm/metabolism , Guanine Nucleotide Exchange Factors/metabolism , Intracellular Signaling Peptides and Proteins , Luminescent Proteins/metabolism , Nuclear Proteins/metabolism , Animals , Binding Sites , Blotting, Western , Carrier Proteins/metabolism , Cell Aggregation , Cell Death , Cell Line , DNA-Binding Proteins , GTPase-Activating Proteins , Glutathione Transferase/genetics , Green Fluorescent Proteins , In Situ Nick-End Labeling/methods , Microscopy, Confocal , Peptide Fragments/metabolism , Precipitin Tests/methods , Protein Binding , Proto-Oncogene Proteins c-myc/metabolism , Repressor Proteins , Sequence Homology, Amino Acid , Transfection , Two-Hybrid System TechniquesABSTRACT
Coculture of eosinophils and nerves is a powerful tool in determining the interactions between the two cell types. We have developed methods for culture of parasympathetic ganglia and dorsal root ganglia from humans, and we have further refined the technique to coculture with eosinophils. Here we describe methods for coculturing primary parasympathetic ganglia or dorsal root ganglia with eosinophils.